MENU ▼
Read by QxMD icon Read
search
OPEN IN READ APP
JOURNAL ARTICLE

Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations in adult liver transplant patients

Camille Riff, Jean Debord, Caroline Monchaud, Pierre Marquet, Jean-Baptiste Woillard
British Journal of Clinical Pharmacology 2019 April 11
30973981

AIMS: Tacrolimus is a narrow therapeutic range drug that requires fine dose adjustment, for which pharmacokinetic models have been amply proposed in renal, but not in liver, transplant recipients. This study aimed to build population pharmacokinetic (POPPK) models and Bayesian estimators (BE) in adult de novo liver transplant patients receiving either the immediate-release (Prograf®, TD) or prolonged-release (Advagraf®, OD) forms to help pharmacokinetics-guided dose individualization.

METHODS: One hundred sixty tacrolimus concentration-time profiles (1654 samples) were collected from 80 patients, at day 7 (D7) and week 6 (W6) post-transplant. Four POPPK models were developed using in parallel parametric (ITSIM) and non-parametric (Pmetrics) approaches for each formulation and period post-transplant. The best limited sampling strategies (LSS) for estimating the area-under-the-curve (AUC) were selected by comparing predicted values to an independent dataset. Finally, the doses required to reach AUC targets were estimated using each BE and compared to the doses obtained using the trapezoidal AUC.

RESULTS: Tacrolimus pharmacokinetics was best described using a one-compartmental model with first-order elimination and two gamma distributions to describe the absorption. In the validation datasets, Bayesian AUC estimates yielded mean bias/RMSE of -5.06%/13.43% (OD D7), 2.25%/8.51% (OD W6), -2.36%/7.27% (TD D7) and 0.87%/9.07% (TD W6) for ITSIM and 8.95%/17.84% (OD D7), -0.11%/10.13% (OD W6), 3.57%/18.40% (TD D7) and 4.48%/12.59% (TD W6) for Pmetrics.

CONCLUSION: The BEs and LSSs proposed here are able to predict accurately and precisely tacrolimus AUC in liver patients using only 3 plasma concentrations. The dosing methods are available on our ISBA website (www.pharmaco.chu-limoges.fr).

Comments

You need to log in or sign up for an account to be able to comment.

No comments yet, be the first to post one!

Related Papers

Available on the App Store

Available on the Play Store
Remove bar
Read by QxMD icon Read
30973981
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"